- Title: Subtitle
- P-39 Utility of circulating tumor DNA (ctDNA) to assess tumor response in patients with locally advanced rectal cancer undergoing neoadjuvant therapy
- Creators
- S. Chakrabarti - Medical College of WisconsinR. Benrud - Natera (United States)J. Chau - University of IowaW. Hall - Medical College of WisconsinA. Shreenivas - Medical College of WisconsinB. Erickson - Medical College of WisconsinC. Peterson - Medical College of WisconsinT RidolfiJ. Miller - Medical College of WisconsinA. Banerjee - Medical College of WisconsinJ. Thomas - Medical College of WisconsinS. Sharif - University of Iowa, Hematology, Oncology, and Blood & Marrow TransplantationN. Fei - University of Iowa, Hematology, Oncology, and Blood & Marrow TransplantationK. Ludwig - Medical College of WisconsinP. Olshan - Natera (United States)C. Palsuledesai - Natera (United States)M. Malhotra - Natera (United States)A. Jurdi - Natera (United States)A. Aleshin - Natera (United States)P. Kasi - Cornell University
- Resource Type
- Abstract
- Publication Details
- Annals of oncology, Vol.33(Supplement 4), pp.S260-S261
- DOI
- 10.1016/j.annonc.2022.04.130
- ISSN
- 0923-7534
- eISSN
- 1569-8041
- Publisher
- ELSEVIER
- Language
- English
- Date published
- 06/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9985166478002771
Abstract
P-39 Utility of circulating tumor DNA (ctDNA) to assess tumor response in patients with locally advanced rectal cancer undergoing neoadjuvant therapy
Annals of oncology, Vol.33(Supplement 4), pp.S260-S261
06/2022
DOI: 10.1016/j.annonc.2022.04.130
Details
Metrics
1 Record Views